Kyntra Bio, Inc. ( KYNB) - Stock Earnings
KYNB Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 10, 2026, midnight | — / — | — | — / — | — |
KYNB Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 200.6 million USD | 1.1 million USD |
| 2025Q4 | -14.2 million USD | 1.3 million USD |
| 2026Q1 | -15.2 million USD | 3.7 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
KYNB Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -271.6 million USD | 147.8 million USD |
| 2024 | -153.1 million USD | 203.3 million USD |
| 2025 | 183.5 million USD | 6.4 million USD |
| 2026 Est. | — | — |
KYNB
Price: $7.22
52 week price:
Earnings Per Share: -12.85 USD
P/E Ratio: -0.54
Exchange: NGM
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Market Capitalization: 29.3 million